Novartis Investigative Site

Obninsk, Russia 249036

0 studies enrolling now · 2 studies all time

What they study most

Adenocarcinoma, Carcinoma, Hypernephroid, Metastatic Renal Cell Carcinoma, Nephroid Carcinoma, Renal Cell

Studies at this site

• Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer — Completed
• Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma — Completed